Stereotaxis (STXS) Expected to Announce Quarterly Earnings on Monday

Stereotaxis (NYSEAMERICAN:STXS) is projected to announce its Q1 2025 earnings results after the market closes on Monday, May 12th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $6.88 million for the quarter.

Stereotaxis Stock Performance

STXS stock opened at $2.13 on Friday. The company has a market capitalization of $180.47 million, a PE ratio of -7.61 and a beta of 1.54. The company’s fifty day moving average price is $1.88 and its 200-day moving average price is $2.07. Stereotaxis has a one year low of $1.54 and a one year high of $2.72.

Insider Buying and Selling at Stereotaxis

In other news, Director Paul J. Isaac acquired 38,000 shares of the company’s stock in a transaction on Monday, March 10th. The stock was bought at an average cost of $1.81 per share, with a total value of $68,780.00. Following the completion of the purchase, the director now directly owns 87,299 shares of the company’s stock, valued at $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 18.52% of the company’s stock.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.